PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

摘要

A combination chemotherapy for treatment of neoplastic diseases is described. Adverse cytotoxic side effects associated with antineoplastic agents may be reduced by the use of a cytoprotective copolymer in combination with the antineoplastic agent. A preferred combination chemotherapy uses doxorubicin to effect tumor remission along with carbetimer as a cytoprotective agent to reduce the toxic side effects associated with doxorubicin and to enhance the antineoplastic activity of doxorubicin.